Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Myotonic Dystrophy Protein Kinase mRNA (DMPK mRNA)
- Target
- DMPK mRNA
- Molecular classification
- RNA, mRNA
01
Overview
Myotonic dystrophy protein kinase mRNA refers to transcripts produced from the human *DMPK* gene. Mutations involving expanded CTG repeats lead to abnormal RNAs that aggregate inside nuclei—causing multisystemic symptoms characteristic of DM1 through disruption of normal cellular functions rather than direct loss of enzymatic activity by the encoded kinase itself. The encoded serine/threonine kinase is vital for maintaining skeletal muscle integrity through regulation at both cytoplasmic signaling pathways and nuclear envelope stability. Therapeutic strategies focus on targeting the mutant mRNA using antisense oligonucleotides or similar approaches.
- Other names
- DM1 mRNAMyotonin-protein kinase mRNA
02
Mechanism of action
Antisense oligonucleotides targeting mutant mRNA
03
Biological functions
mRNA ProcessingRegulation of gene expressionRNA toxicity
04
Disease associations
Myotonic Dystrophy Type 1 (DM1)
05
Safety considerations
Off-target effects of antisense oligonucleotidesDelivery challenges to affected tissuesPotential for immune response to therapeutic oligonucleotides
06
Biomarkers
CTG repeat length in DMPK gene
Beyond the preview
Go deeper on Myotonic Dystrophy Protein Kinase mRNA (DMPK mRNA).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow the clinical studies evaluating therapies directed at this target.
- Trial design
- Status
- Readouts
Competitive landscape
Full profile accessCompare approaches across drug candidates, modalities, and indications.
- Programs
- Modalities
- Indications
Literature & evidence
Full profile accessInvestigate the research and source evidence behind target biology and development.
- Publications
- Sources
- Analysis
Patents
Full profile accessExplore patent activity around therapies and technologies addressing this target.
- Patents
- Assignees
- Technologies
Research & analysis
Full profile accessConnect target biology, drug development, and emerging evidence in your research.
- Biology
- Development news
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Myotonic Dystrophy Protein Kinase mRNA (DMPK mRNA).